Literature DB >> 12382199

Juvenile hemochromatosis.

Clara Camaschella1, Antonella Roetto, Marco De Gobbi.   

Abstract

Juvenile hemochromatosis or type 2 hemochromatosis is a rare inherited recessive disease, which leads to severe iron overload earlier in life than HFE-related hemochromatosis. Increased transferrin saturation and serum ferritin as well as parenchymal iron deposition and liver fibrosis may be observed in childhood. Clinical symptoms of hypogonadism and cardiac disease develop before the age of 30. The disease is usually progressive and if untreated may become fatal because of heart failure. The type 2 hemochromatosis locus maps to chromosome 1q21, but the gene has not yet been isolated. The severity and the early expression of juvenile hemochromatosis suggest that the gene product has a crucial role in the regulation of iron homeostasis. Copyright 2002, Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12382199     DOI: 10.1053/shem.2002.35635

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  15 in total

1.  Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis.

Authors:  D M Frazer; H R Inglis; S J Wilkins; K N Millard; T M Steele; G D McLaren; A T McKie; C D Vulpe; G J Anderson
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

2.  Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha.

Authors:  Marco Constante; Dongmei Wang; Valérie-Ann Raymond; Marc Bilodeau; Manuela M Santos
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression.

Authors:  An-Sheng Zhang; Fan Yang; Jiaohong Wang; Hidekazu Tsukamoto; Caroline A Enns
Journal:  J Biol Chem       Date:  2009-06-29       Impact factor: 5.157

4.  Control of systemic iron homeostasis by the hemojuvelin-hepcidin axis.

Authors:  An-Sheng Zhang
Journal:  Adv Nutr       Date:  2010-11-16       Impact factor: 8.701

Review 5.  Repulsive guidance molecules (RGMs) and neogenin in bone morphogenetic protein (BMP) signaling.

Authors:  Chenxi Tian; Jun Liu
Journal:  Mol Reprod Dev       Date:  2013-07-19       Impact factor: 2.609

6.  Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.

Authors:  Sara Gardenghi; Maria F Marongiu; Pedro Ramos; Ella Guy; Laura Breda; Amy Chadburn; YiFang Liu; Ninette Amariglio; Gideon Rechavi; Eliezer A Rachmilewitz; William Breuer; Z Ioav Cabantchik; Diedra M Wrighting; Nancy C Andrews; Maria de Sousa; Patricia J Giardina; Robert W Grady; Stefano Rivella
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

Review 7.  Hemojuvelin: a supposed role in iron metabolism one year after its discovery.

Authors:  Peter Celec
Journal:  J Mol Med (Berl)       Date:  2005-05-05       Impact factor: 4.599

8.  Contributions of beta2-microglobulin-dependent molecules and lymphocytes to iron regulation: insights from HfeRag1(-/-) and beta2mRag1(-/-) double knock-out mice.

Authors:  Carlos J Miranda; Hortence Makui; Nancy C Andrews; Manuela M Santos
Journal:  Blood       Date:  2003-12-04       Impact factor: 22.113

9.  Neogenin-mediated hemojuvelin shedding occurs after hemojuvelin traffics to the plasma membrane.

Authors:  An-Sheng Zhang; Fan Yang; Kathrin Meyer; Catalina Hernandez; Tara Chapman-Arvedson; Pamela J Bjorkman; Caroline A Enns
Journal:  J Biol Chem       Date:  2008-04-29       Impact factor: 5.157

10.  Diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation.

Authors:  M De Gobbi; R Caruso; F Daraio; F Chianale; R M Pinto; F Longo; A Piga; C Camaschella
Journal:  Eur J Pediatr       Date:  2002-12-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.